Dhar, A.; Johnson, K. S.; Novelli, M. R.; Bown, S. G.; Lovat, L. B.; Bloom, S. L.
April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA9
Academic Journal
Diagnosis of colonic pathology requires conventional histology of multiple biopsies, which has a high sampling error and a low diagnostic yield. Elastic Scattering Spectroscopy (ESS) is a novel optical technique, which can distinguish between normal and abnormal tissue instantaneously in vivo. Authors present their initial results using thisnovel technology in the colon. Despite small data sets particularly for hyperplastic polyps, these data suggest that ESS may be capable of differentiating various colonic lesions in real time allowing an in vivo optical biopsy measurement. It may be valuable in targeting polypectomy and dysplasia surveillance in patients with chronic ulcerative colitis.


Related Articles

  • Early surgical intervention in ulcerative colitis. Kamm, M. A. // Gut;Feb2004, Vol. 53 Issue 2, p308 

    The article focuses on the medical treatment for both fulminant and chronic active colitis. Intravenous cyclosporin is effective in managing fulminant ulcerative colitis. Cyclosporin can be continued even if there is mild colonic dilatation, provided the patient is clinically improving. After...

  • Strategies to Improve Adherence and Outcomes in Patients with Ulcerative Colitis. Kane, Sunanda V. // Drugs;2008, Vol. 68 Issue 18, p2601 

    This review examines studies of patient adherence to 5-aminosalicylic acid therapy conducted outside the context of a controlled therapy trial, considers the reasons why patients do not adhere to their medication and its consequences, and interventions to improve adherence and disease outcomes....

  • Dramatic And Long Lasting Efficiency (13 Years) Of Oral 5 Aspirin. Maroy, Bernard // Internet Journal of Academic Physician Assistants;2003, Vol. 3 Issue 1, p12 

    Introduction: Could 5 ASA be an option in case of cortico-resistant and/or intolerant ulcerative colitis? Case report: A 55-year-old woman was referred for a recent, moderately severe, left-sided ulcerative colitis. The response to corticotherapy was initially fair, then mediocre, complicated by...

  • The Microvacular Thrombi of Colonic Tissue in Ulcerative Colitis. Guobin He; Qin Ouyang; Daiyun Chen; Fengyuan Li; Jingguo Zhou // Digestive Diseases & Sciences;Sep2007, Vol. 52 Issue 9, p2236 

    Abstract  Mucosal microvacular thrombi in rectal biopsies were observed in some ulcerative colitis (UC). Heparin may be effective in steroid resistant UC in some studies, however, the new results of meta-analysis demonstrated a non-significant effect of heparin in controlled...

  • Leukocytapheresis (LCAP) in the Management of Chronic Active Ulcerative Colitis—Results of a Randomized Pilot Trial. Jörg Emmrich; Sebastian Petermann; Dietrich Nowak; Ingolf Beutner; Peter Brock; Patrick Mausfeld-Lafdhiya; Stefan Liebe; Wolfgang Ramlow // Digestive Diseases & Sciences;Sep2007, Vol. 52 Issue 9, p2044 

    Abstract  Recent studies suggest that leukocytapheresis with Cellsorba is a valuable therapy for ulcerative colitis after failure of conventional treatment. In this study the potential of leukocytapheresis to induce remission in refractory chronic colitis under the conditions of...

  • Meta-Analysis of the Placebo Response in Ulcerative Colitis. Sagar Garud; Alphonso Brown; Adam Cheifetz; Emily Levitan; Ciaran Kelly // Digestive Diseases & Sciences;Apr2008, Vol. 53 Issue 4, p875 

    Abstract   Purpose The placebo response rate in randomized controlled trials (RCTs) in ulcerative colitis (UC) varies from 0 to 76%. The aims of this study were to quantify the pooled placebo response rate and identify the factors affecting it. Methods We performed a...

  • Abnormalities in colonic mucin may contribute to the persistence of colonic mucosal inflammation.  // Journal of Gastroenterology;2000, Vol. 35 Issue 1, p71 

    Editorial. Deals with the possible contribution of the abnormalities in colonic mucin to the persistence of colonic mucosal inflammation. Percentage of ulcerative colitis patients with circulating antibodies to colonocytes; Number of reported mucin genes; Description of MUC2 mucin; Candidate...

  • A Population-based Ecologic Study of Inflammatory Bowel Disease: Searching for Etiologic Clues. Chris Green; Lawrence Elliott; Carole Beaudoin; Charles N. Bernstein // American Journal of Epidemiology;Oct2006, Vol. 164 Issue 7, p615 

    The authors' objective in this study was to determine geographic variations in the incidence of inflammatory bowel disease (IBD), specifically Crohn's disease and ulcerative colitis, in the Canadian province of Manitoba and its association with the sociodemographic, geographic, and...

  • Aminosalicylate (Major drug group).  // Royal Society of Medicine: Medicines;2002, p52 

    The article provides information on aminosalicylate agents, a chemical class of drugs that contain a 5-aminosalicylic acid component. They are used to maintain remission of the symptoms of ulcerative colitis, also to treat active Crohn's disease; also, they can be used to treat rheumatoid...


Read the Article


Sign out of this library

Other Topics